THE TAPE
AVAH · Home Health Care Services · $2.5B

Aveanna Healthcare Holdings Inc. Common Stock

$11.63▲ +1.13%
Last close
Relative strength
81RS
of 99, against every stock▼ -10 on the month
Cooling off
Unconfirmed
+50.8%
six months against the S&P 500
52-week range
−20.9%
from the high
$5.93$14.71
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Oct 3, revenue +12% on a year ago
Why it is on no screen

AVAH is off the screens on one check: close to its pivot.

A base has formed8.8 weeks, from 11.31 to 14.71.
Long enough to count8.8 weeks against 3 needed.
Shallow enough23.1% deep against 35% allowed.
Close to its pivot-20.9% from the pivot; listed down to -20%.
Relative strengthRS 81 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$9.99
-14.1% · tested 3× · last 77 sessions ago
Resistance above
$12.25
+5.3% · tested 7× · last 13 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Aveanna Healthcare Holdings Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 81, and it sits in Home Health Care Services.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
-2.8%
Three months against the S&P 500
-4.8%
Six months against the S&P 500
+50.8%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 22.7% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$2.7B
+11.8% year on year
Operating margin
11.4%
gross 32.3%
Net margin
3.0%
Free cash flow
$207.2M
8.2% of market cap
Price to sales
0.95×
Price to earnings
31.2×

Twelve months to Oct 3, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 12
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$695.5M
+3.7% QoQ · +11.8% YoY
Gross margin
32.6%
0.0 pts QoQ
Net income
$45.5M
Positive
Free cash flow
$72.2M
Cash generating

What the numbers say

  • Revenue +11.8% year over year, +3.7% on the quarter
  • Gross margin 32.6%, +0.0 points on the quarter
  • Good: Profitable: net income $45M, operating margin 12.0%
  • Good: Cash generating: operating cash flow $72M, free cash flow $72M
  • Net debt $1.10B · cash $198M
Revenue by quarter
Free cash flow
Net income
shares +3.1% in a year · net debt $1.1B

The desk’s own read

Flagged as drifting down since the report

Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 added, 1 sold out.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
GappedTape · 2026-11-14
-6.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Reported resultsFiling · 2026-11-13
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Closed below its 20- and 50-day on heavy volumeTape · 2026-11-13
below 20d & 50d on 2.1x volume at 12.24
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
GappedTape · 2026-11-13
-6.5%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ down on earningsTape · 2026-11-13
-6.5% on earnings 2026-11-12
No measurable effect: stocks behave like random ones over the next three sessions (665 cases over 44 nights).
Earnings comingEvent · 2026-11-11
reports 2026-11-12 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Pulled back while its group leadsTape · 2026-11-10
3 lower closes in a leading group, 50d held, at 13.20
Mixed: stocks have lagged random stocks by 1.0% over three sessions, not consistently enough to call (433 cases over 59 nights). Against their own sector they have lagged by 0.9%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-05
above 20d & 50d on 1.6x volume at 14.23
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
40
$773,117,091 total

Sold: J.H. Whitney Equity Partners VII, LLC, WILLIAMS ROBERT M JR, VIGANO PAUL R, Windley Rodney D, Shaner Jeff, Reisz Edwin C..

Not counted above: 1 filing for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-10-01 Stewart Deborah · SVP, Chief Accounting Officeraward75,000
2026-08-21 J.H. Whitney Equity Partners VII, LLC · 10% ownersell2,250,000$25,875,000
2026-08-21 WILLIAMS ROBERT M JR · 10% ownersell2,250,000$25,875,000
2026-08-21 VIGANO PAUL R · 10% ownersell2,250,000$25,875,000
2026-08-20 J.H. Whitney Equity Partners VII, LLC · 10% ownersell10,112,125$116,289,438
2026-08-20 J.H. Whitney Equity Partners VII, LLC · 10% ownersell957,918$11,016,057
2026-08-20 J.H. Whitney Equity Partners VII, LLC · 10% ownersell1,426,034$16,399,391
2026-08-20 WILLIAMS ROBERT M JR · 10% ownersell10,112,125$116,289,438

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What analysts expect
Strong buy2
Buy6
Hold3
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Aveanna Healthcare Holdings Inc. Common Stock (AVAH) — The Tape